Assessment of EGFR Genomic Alterations as Prognostic Markers in Cervical Cancer
NCT00298064
·
clinicaltrials.gov ↗
NA
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Conditions
Cervical Cancer
Cervix
Interventions
GENETIC:
Tissue Repository
Sponsor
University of New Mexico